ascopubs.org

Alliance A221805: Duloxetine to prevent oxaliplatin-induced chemotherapy-induced peripheral neuropathy (CIPN)—A randomized, double-blind, placebo-controlled phase II study.

A randomized controlled trial of cognitive behavioral therapy and bright light therapy for insomnia and fatigue during breast cancer treatment: SleepCaRe trial. Peri-transplant supportive and ...
ascopubs.org

Phase II trial of transarterial chemoembolization followed by sintilimab (anti-PD-1), oxaliplatin, and S-1 combined with either trastuzumab (HER-2 positive) or apatinib (HER-2 ...

Clinical outcomes of first-line immune checkpoint inhibitors with chemotherapy in advanced EBV-associated gastric cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...